Literature DB >> 20842025

Further validation of the BDI-II among people with chronic pain originating from musculoskeletal disorders.

Marc Corbière1, Arielle Bonneville-Roussy, Renée-Louise Franche, Marie-France Coutu, Manon Choinière, Marie-José Durand, Aline Boulanger.   

Abstract

OBJECTIVE: One criticism of the BDI-II for assessing depressive symptoms in people experiencing chronic pain has been the potential overlap between the physical or psychological origins of some of the symptoms. Furthermore, previous studies have reported both two-factor and three-factor solutions, so that the factor solution of the instrument in this population remains unclear. The main objective of the present study was to validate the BDI-II with a chronic pain population experiencing musculoskeletal disorders. Three specific objectives were: (1) to modify the BDI-II for people with musculoskeletal disorders by adding sub-questions to better identify the perceived cause of the depressive symptoms, (2) to assess the validity and reliability of this modified version of the BDI-II, and (3) to explore the perceptions of the causes/origins of symptoms reported on the BDI-II. Results of the confirmatory factor analysis supported the presence of three dimensions within the BDI- : Cognitive, Affective and Somatic.
METHODS: A total of 206 participants experiencing chronic pain answered a modified version of the BDI-II, the CES-D and a sociodemographic questionnaire.
RESULTS: Results confirmed the three-dimensional factorial structure of the BDI for this population. Overall, participants experienced higher levels of somatic symptoms compared to symptoms belonging to other dimensions. The percentages of answers to the sub-questions were also similarly distributed between "pain", and "pain and state of mind", regardless of the dimension. DISCUSSION: The importance of assessing somatic symptoms of depression in pain patients and of thoroughly examining the underlying perceived cause of symptoms, regardless of the dimension, are discussed.

Entities:  

Mesh:

Year:  2011        PMID: 20842025     DOI: 10.1097/AJP.0b013e3181eef903

Source DB:  PubMed          Journal:  Clin J Pain        ISSN: 0749-8047            Impact factor:   3.442


  9 in total

1.  Interdisciplinary treatment of patients with multiple sclerosis and chronic pain: a descriptive study.

Authors:  Amy Burleson Sullivan; Judith Scheman; Anthony Lopresti; Heather Prayor-Patterson
Journal:  Int J MS Care       Date:  2012

2.  The impact of comorbid spinal pain in depression on work participation and clinical remission following brief or short psychotherapy. Secondary analysis of a randomized controlled trial with two-year follow-up.

Authors:  Marjon E A Wormgoor; Aage Indahl; Jens Egeland
Journal:  PLoS One       Date:  2022-08-22       Impact factor: 3.752

3.  Possible Contribution of Meaning in Life in Patients With Chronic Pain and Suicidal Ideation: Observational Study.

Authors:  Vasileios Chytas; Alessandra Costanza; Viridiana Mazzola; Christophe Luthy; Vasiliki Galani; Guido Bondolfi; Christine Cedraschi
Journal:  JMIR Form Res       Date:  2022-06-13

4.  Psychometric testing of the Chinese version of the Medical Outcomes Study Social Support Survey among people living with HIV/AIDS in China.

Authors:  Yu Yu; Joyce P Yang; Cheng-Shi Shiu; Jane M Simoni; Shuiyuan Xiao; Wei-Ti Chen; Deepa Rao; Mingjiong Wang
Journal:  Appl Nurs Res       Date:  2015-03-12       Impact factor: 2.257

5.  Factor structure of the children's depression inventory in a multisite sample of children and adolescents with chronic pain.

Authors:  Deirdre E Logan; Robyn Lewis Claar; Jessica W Guite; Susmita Kashikar-Zuck; Anne Lynch-Jordan; Tonya M Palermo; Anna C Wilson; Chuan Zhou
Journal:  J Pain       Date:  2013-04-30       Impact factor: 5.820

6.  Adherence to Antiretroviral Therapy (ART) in Yaoundé-Cameroon: Association with Opportunistic Infections, Depression, ART Regimen and Side Effects.

Authors:  Julius Y Fonsah; Alfred K Njamnshi; Charles Kouanfack; Fang Qiu; Dora M Njamnshi; Claude T Tagny; Emilienne Nchindap; Léopoldine Kenmogne; Dora Mbanya; Robert Heaton; Georgette D Kanmogne
Journal:  PLoS One       Date:  2017-01-31       Impact factor: 3.240

7.  Depressive symptoms in HIV-infected and seronegative control subjects in Cameroon: Effect of age, education and gender.

Authors:  Georgette D Kanmogne; Fang Qiu; Félicien E Ntone; Julius Y Fonsah; Dora M Njamnshi; Callixte T Kuate; Roland F Doh; Anne M Kengne; Claude T Tagny; Emilienne Nchindap; Léopoldine Kenmogne; Dora Mbanya; Mariana Cherner; Robert K Heaton; Alfred K Njamnshi
Journal:  PLoS One       Date:  2017-02-23       Impact factor: 3.240

Review 8.  Assessment of depression in medical patients: a systematic review of the utility of the Beck Depression Inventory-II.

Authors:  Yuan-Pang Wang; Clarice Gorenstein
Journal:  Clinics (Sao Paulo)       Date:  2013-09       Impact factor: 2.365

9.  Adaptation and Latent Structure of the Swahili Version of Beck Depression Inventory-II in a Low Literacy Population in the Context of HIV.

Authors:  Amina Abubakar; Raphael Birya Kalu; Khamis Katana; Beatrice Kabunda; Amin S Hassan; Charles R Newton; Fons Van de Vijver
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.